Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male

• Low grade serous (LGS) ovarian cancer is an uncommon cancer. • Androgen receptor expression testing is not routinely performed in patients with LGS ovarian cancer. • Systemic androgen levels may be elevated in patients with PCOS or those taking exogenous testosterone. • Consideration should be mad...

Descripción completa

Detalles Bibliográficos
Autores principales: Smrz, Stacy A, Chapman, Graham, Gordon, Jennifer, Bagby, Christina, Nascimento, Alessandra, Ferguson, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160689/
https://www.ncbi.nlm.nih.gov/pubmed/37152242
http://dx.doi.org/10.1016/j.gore.2023.101190
_version_ 1785037335870570496
author Smrz, Stacy A
Chapman, Graham
Gordon, Jennifer
Bagby, Christina
Nascimento, Alessandra
Ferguson, Lindsay
author_facet Smrz, Stacy A
Chapman, Graham
Gordon, Jennifer
Bagby, Christina
Nascimento, Alessandra
Ferguson, Lindsay
author_sort Smrz, Stacy A
collection PubMed
description • Low grade serous (LGS) ovarian cancer is an uncommon cancer. • Androgen receptor expression testing is not routinely performed in patients with LGS ovarian cancer. • Systemic androgen levels may be elevated in patients with PCOS or those taking exogenous testosterone. • Consideration should be made to include androgen receptor testing for these patients.
format Online
Article
Text
id pubmed-10160689
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101606892023-05-06 Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male Smrz, Stacy A Chapman, Graham Gordon, Jennifer Bagby, Christina Nascimento, Alessandra Ferguson, Lindsay Gynecol Oncol Rep Case Report • Low grade serous (LGS) ovarian cancer is an uncommon cancer. • Androgen receptor expression testing is not routinely performed in patients with LGS ovarian cancer. • Systemic androgen levels may be elevated in patients with PCOS or those taking exogenous testosterone. • Consideration should be made to include androgen receptor testing for these patients. Elsevier 2023-04-15 /pmc/articles/PMC10160689/ /pubmed/37152242 http://dx.doi.org/10.1016/j.gore.2023.101190 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Smrz, Stacy A
Chapman, Graham
Gordon, Jennifer
Bagby, Christina
Nascimento, Alessandra
Ferguson, Lindsay
Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title_full Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title_fullStr Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title_full_unstemmed Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title_short Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
title_sort androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160689/
https://www.ncbi.nlm.nih.gov/pubmed/37152242
http://dx.doi.org/10.1016/j.gore.2023.101190
work_keys_str_mv AT smrzstacya androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale
AT chapmangraham androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale
AT gordonjennifer androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale
AT bagbychristina androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale
AT nascimentoalessandra androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale
AT fergusonlindsay androgenreceptorexpressioninlowgradeserousovariancancerclinicalconsiderationsinthediagnosistreatmentandsurveillanceofdiseaseinatransgendermale

Ejemplares similares